市场调查报告书
商品编码
1308150
医疗器械外包市场:2023-2028年全球行业趋势、份额、规模、增长、机会及预测Medical Device Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球医疗器械外包市场规模达到1157亿美元。展望未来,IMARC集团预计到2028年,该市场规模将达到1990.6亿美元,2023-2028年期间的年复合增长率(CAGR)为9%。对高质量、可负担的医疗保健服务的需求不断增长,医疗疾病的发病率不断上升,以及行业技术的不断进步是推动市场发展的一些关键因素。
医疗器械外包包括以合同形式将整个医疗器械生产任务转包给第三方供应商。这反过来有助于企业降低成本、简化供应链,并在遵守行业标准和要求的同时将商业产品推向市场。它还能提高运营效率和产品质量,最大限度地降低业务风险,加快产品开发周期和市场进入速度,并提供获得先进技术的途径。医疗器械外包包括一系列服务,如器械组装和包装、包装测试和灭菌验证、重复加工和流程改进鉴定。除此之外,许多行业参与者还提供专业设施,包括现场医疗实验室和洁净室,以确保医疗器械的无污染生产。
医疗疾病的日益普遍促进了对高质量医疗服务的需求,这是推动市场增长的主要因素。通过创新和持续研发(R&D)投资扩大产品组合的需求不断增长,也进一步支持了这一需求。此外,与外包医疗器械生产和开发相关的成本效益也为市场创造了有利前景。此外,对医疗器械的监管要求不断提高,促使领先的市场参与者与合规外包公司合作,以确保其产品及时获得批准,同时遵守严格的政府产品安全法规。这反过来又为市场带来了可观的增长机会。因此,合规外包使制造商能够专注于其核心竞争力,并在满足新兴市场需求的同时保持生产成本,这有利于市场的增长。除此之外,医疗保健行业的增长、老年人口的增加、医疗器械技术的不断进步、消费者意识的提高以及对患者安全和护理质量的日益关注,都有助于市场的扩大。此外,个性化医疗需求的激增、可穿戴医疗设备应用的不断扩大、微创外科手术的普及以及家庭医疗、远程医疗和医疗旅游的新兴趋势也促进了市场的增长。
The global medical device outsourcing market size reached US$ 115.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 199.6 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028. The rising demand for quality and affordable healthcare services, the increasing prevalence of medical ailments, and ongoing technological advancements in the industry represent some of the key factors driving the market.
Medical device outsourcing involves subletting the entire production task of medical devices to a third-party vendor on a contract basis. This, in turn, helps organizations reduce expenses, streamline the supply chain, and bring commercial products to market while adhering to industry standards and requirements. It also improves operational efficiency and product quality, minimizes business risks, accelerates products' development cycles and market entry, and provides access to advanced technologies. Medical device outsourcing includes a range of services such as device assembly and packaging, as well as package testing and sterilization validation, recurring processing, and process improvement identification. In addition to this, many industry players offer specialized facilities, including on-site medical labs and cleanrooms, to ensure the contamination-free production of medical devices.
The increasing prevalence of medical ailments has facilitated the need for quality healthcare services, which represents the prime factor driving the market growth. This is further supported by the rising need to expand product portfolios through innovations and constant research and development (R&D) investments. Besides this, the cost-effectiveness associated with outsourcing medical device manufacturing and development is creating a favorable outlook for the market. Moreover, the increasing regulatory requirement for medical devices is prompting leading market players to collaborate with regulatory compliance outsourcing companies to ensure timely approval of their products while adhering to stringent government regulations on product safety. This, in turn, is presenting remunerative growth opportunities for the market. In line with this, outsourcing regulatory compliance allows manufacturers to focus on their core competencies and maintain production costs while addressing the needs of the emerging market, which is favoring the market growth. In addition to this, the bolstering growth of the healthcare sector, the rising geriatric population, and ongoing technological advancements in medical devices, combined with the escalating consumer awareness and the increasing focus on patient safety and quality of care, are aiding in market expansion. Furthermore, the surging demand for personalized medicine, the expanding adoption of wearable medical devices, the shifting popularity of minimally invasive surgical procedures, and the emerging trend of home healthcare, telemedicine, and medical tourism are contributing to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical device outsourcing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, therapeutics and application.
Regulatory Consulting
Product Design and Development
Product Testing and Sterilization
Product Implementation
Product Upgrade
Product Maintenance
The report has provided a detailed breakup and analysis of the medical device outsourcing market based on the service. This includes regulatory consulting, product design and development, product testing and sterilization, product implementation, product upgrade, and product maintenance. According to the report, product design and development represented the largest segment.
Cardiology
Diagnostic Imaging
Orthopedic
IVD
Ophthalmic
General and Plastic Surgery
Drug Delivery
Dental
Endoscopy
Diabetes Care
A detailed breakup and analysis of the medical device outsourcing market based on therapeutics have also been provided in the report. This includes cardiology, diagnostic imaging, orthopedic, IVD, ophthalmic, general and plastic surgery, drug delivery, dental, endoscopy, and diabetes care. According to the report, cardiology accounted for the largest market share.
Class I
Class II
Class III
The report has provided a detailed breakup and analysis of the medical device outsourcing market based on the application. This includes class I, II, and III. According to the report, class II represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for medical device outsourcing. Some of the factors driving the Asia Pacific medical device outsourcing market included the rising prevalence of chronic diseases, the expanding geriatric population, and continuous technological advancements in medical devices.
The report has also provided a comprehensive analysis of the competitive landscape in the global medical device outsourcing market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Celestica Inc. (Onex Corporation), Charles River Laboratories International Inc., Flex Ltd., Freyr Inc., Heraeus Holding GmbH, ICON plc, Integer Holdings Corporation, IQVIA Inc., Plexus Corp., Sanmina Corporation, TE Connectivity, and West Pharmaceutical Services Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.